Shanghai Fosun Pharmaceutical climbs on vaccine unit's Hong Kong listing plan
I'm PortAI, I can summarize articles.
** Shanghai Fosun Pharmaceutical's Hong Kong shares climb 3.1% to HK$20.86, set for biggest one-day pct gain since Jan 13** Shanghai-listed stock adds 1.7% to 27.72 yuan, biggest one-day pct rise since Jan 5** Healthcare group's board of directors approves proposed spin-off and listing of vaccine unit Fosun Adgenvax (Chengdu) Biopharmaceutical in Hong Kong** Spin-off and listing subject to shareholder, China Securities Regulatory Commission, the Stock Exchange and other authorities approvals - co** YTD, Hong Kong stock up 5.2%, Shanghai-listed shares up 3.9%
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments